Bafna Pharma Independent Director Retires, Committees Reconstituted

Bafna Pharmaceuticals Ltd announced the retirement of Mr. Navin Kumar as an Independent Director, effective June 22, 2026, upon completion of his first term. Consequently, he will also step down as Chairman of the Audit Committee and the Nomination & Remuneration Committee. The company has reconstituted these committees effective June 23, 2026, with new chairpersons and members appointed. Bafna Pharmaceuticals confirmed that the board and committee compositions remain compliant with applicable regulations.